Dana–Farber Cancer Institute
PulseAugur coverage of Dana–Farber Cancer Institute — every cluster mentioning Dana–Farber Cancer Institute across labs, papers, and developer communities, ranked by signal.
2 day(s) with sentiment data
-
Memorial Sloan Kettering shares cancer data via OpenEvidence
Memorial Sloan Kettering Cancer Center is making its extensive cancer data accessible to medical professionals nationwide via the OpenEvidence platform. This initiative aims to broaden access to valuable clinical inform…
-
FDA approves Revolution Medicines' pancreatic cancer pill Rasonque
The FDA has approved Rasonque, a new daily pill from Revolution Medicines, designed to target RAS protein mutations that drive tumor growth in pancreatic cancer. This approval marks a significant breakthrough, as it val…
-
Dr. Charles W. M. Roberts named new CEO of St. Jude Children's Research Hospital
St. Jude Children's Research Hospital has appointed Dr. Charles W. M. Roberts as its new president and CEO, effective January 1st. Roberts, who previously directed the hospital's Comprehensive Cancer Center, aims to lev…
-
Microsoft Research launches AI-powered Project Ex Vivo for cancer research
Microsoft Research, in collaboration with the Broad Institute and Dana-Farber Cancer Institute, has introduced Project Ex Vivo. This initiative leverages AI to enhance the understanding of cancer cell states and support…
-
Experimental pill nearly doubles survival for advanced pancreatic cancer
A new experimental pill, daraxonrasib, has shown significant promise in treating advanced pancreatic cancer by targeting a mutated protein that fuels tumor growth. In a study, patients taking the daily pill nearly doubl…